The following is a summary of “Cross-trait GWAS in COVID-19 and systemic sclerosis reveals novel genes implicated in fibrotic ...

Among the total systemic sclerosis cohort, 14% of individuals were categorized as frail and 53% as prefrail, with frailty status linked to an increased risk for mortality.

The following is a summary of “Foot peripheral sensory neuropathy: a frequent disabling manifestation in systemic sclerosis,” ...

Sildenafil was effective for reducing diastolic dysfunction and altered ejection fraction among patients with SSc.

A new study found no significant benefit in adding low-dose oral glucocorticoids to immunosuppressive therapy for improving skin fibrosis in patients with early diffuse cutaneous systemic ...

Systemic sclerosis, also termed scleroderma, is a multisystem connective tissue disease involving autoimmunity, inflammation, fibrosis and vasculopathy. The clinical presentation of systemic ...

Type I interferon (IFN) score may effectively predict disease progression in limited cutaneous systemic sclerosis (lcSSc), with patients having a high IFN activity presenting worse clinical outcomes.

The odds of developing systemic lupus erythematosus or systemic sclerosis appear to significantly increase with the use of menopausal hormone therapy, according to data published in Rheumatology.

Acute and chronic renal diseases remain common complications of systemic sclerosis. Although treatment for acute scleroderma renal crisis may arrest the rapid progression of renal disease ...

Cabaletta’s new data slice for its investigational CD19-CAR T cell therapy shows “robust benefit” for patients with lupus and ...

Which of the statements below about the most recent guideline for the screening and monitoring of ILD among patients with SARDs are correct? Select 1 option for each question, then submit your answers ...

The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell ...